参考文献/References:
[1] XU M Q,SUN K,CAO C,et al.Age-related twin-peak prevalence profiles of H.pylori infection,gastritis,GIN and gastric cancer:analyses of 70,534 patients with gastroscopic biopsies[J].PLoS One,2022,17(7):e0265885.
[2] LIU C,NG S K,DING Y,et al.Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis[J].Oncogene,2022,41(28):3599-3610.
[3] VAHIDI S,MIRZAJANI E,NOROLLAHI S E,et al.Performance of DNA methylation on the molecular pathogenesis of Helicobacter pylori in gastric cancer;targeted therapy approach[J].J Pharmacopuncture,2022,25(2):88-100.
[4] PARK C H,LEE A R,LEE Y R,et al.Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing[J].Helicobacter,2019,24(1):e12547.
[5] GENG H,DONG Z,ZHANG L,et al.An immune signature for risk stratification and therapeutic prediction in Helicobacter pylori-infected gastric cancer[J].Cancers (Basel),2022,14(13):3276.
[6] NAGASAKI N,ITO M,BODA T,et al.Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings:a large-scale retrospective cohort study[J].BMC Gastroenterol,2022,22(1):299.
[7] XIE P,YAN J,WU M,et al.CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis[J].Ann Transl Med,2022,10(12):689.
[8] LUBANSKA D,ALRASHED S,MASON G T,et al.Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles[J].Sci Rep,2022,12(1):12078.
[9] WEICHERT W,DENKERT C,BURKHARDT M,et al.Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival[J].Clin Cancer Res,2005,11(18):6574-6581.
[10] VILLARD A V,GENNA A,LAMBERT J,et al.Regulation of tissue factor by CD44 supports coagulant activity in breast tumor cells[J].Cancers (Basel),2022,14(13):3288.
[11] SIHOMBING U H M,ANDRIJONO,PURWOTO G,et al.Expression of CD44+/CD24-,RAD6 and DDB2 on chemotherapy response in ovarian cancer:a prospective flow cytometry study[J]. Gynecol Oncol Rep,2022,42:101005.
[12] SINGH A,SPITZER M H,JOY J P,et al.Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes[J].Proc Natl Acad Sci U S A,2022,119(18):e2115567119.
[13] JIA R,GUO X,LIU H,et al.Analysis of staged features of gastritis-cancer transformation and identification of potential biomarkers in gastric cancer[J].J Inflamm Res,2022,15:6857-6868.
[14] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[15] SANO T,COIT D G,KIM H H,et al.Proposal of a new stage grouping of gastric cancer for TNM classification:international gastric cancer association staging project[J].Gastric Cancer,2017,20(2):217-225.
[16] BALI P,COKER J,LOZANO-POPE I,et al.Microbiome signatures in a fast- and slow-progressing gastric cancer murine model and their contribution to gastric carcinogenesis[J].Microorganisms,2021,9(1):189.
[17] AHADI A.Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression[J]. IUBMB Life,2020,72(5):884-898.
[18] ZHU X,SU T,WANG S,et al.New advances in nano-drug delivery systems:Helicobacter pylori and gastric cancer[J].Front Oncol,2022,12:834934.
[19] LIU X,SHAO L,LIU X,et al.Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer[J].EBioMedicine,2019,40:336-348.
[20] MOKHTARIAN R,TABATABAEIAN H,SAADATMAND P,et al.CD44 gene rs8193 C allele is significantly enriched in gastric cancer patients[J].Cell J,2020,21(4):451-458.
[21] SOHN S H,KIM B,SUL H J,et al.Foretinib inhibits cancer stemness and gastric cancer cell proliferation by decreasing CD44 and c-MET signaling[J].Onco Targets Ther,2020,13:1027-1035.
[22] ELAKAD O,HUPL B,LABITZKY V,et al.Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer[J].NPJ Precis Oncol,2022,6(1):52.
[23] GUO T,ZHU Y,YUE M,et al.The therapeutic effects of DDP/CD44-shRNA nanoliposomes in AMF on ovarian cancer[J].Front Oncol,2022,12:811783.
[24] GAO X,LU C,CHEN C,et al.ARPP-19 mediates herceptin resistance via regulation of CD44 in gastric cancer[J].Onco Targets Ther,2020,13:6629-6643.
[25] DMMRICH J,VOLLMERS H P,HEIDER K H,et al.Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading[J].J Mol Med (Berl),1995,73(8):395-401.
[26] PARK J Y,SEO H,KANG C S,et al.Dysbiotic change in gastric microbiome and its functional implication in gastric carcinogenesis[J].Sci Rep,2022,12(1):4285.
[27] LIU N,QI D,JIANG J,et al.Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer[J].Oncol Lett,2022,23(6):193.
[28] LIU X,ZHAO Y,ZHANG W,et al.Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis[J].Onco Targets Ther,2018,11:3087-3100.
[29] MIHANFAR A,YOUSEFI B,GHAZIZADEH DARBAND S,et al.Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP[J].Bioimpacts,2021,11(4):253-261.
[30] KIM W J,KIM W,BAE J M,et al.Dehydroabietic acid is a novel survivin inhibitor for gastric cancer[J].Plants (Basel),2021,10(6):1047.
[31] HASEGAWA T,SUGIHARA T,HOSHINO Y,et al.Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein survivin in a light-independent manner[J].Oncol Lett,2021,22(4):703.
〖KH-2\*4〗
[32] BURY J,SZUMIO J,D〖KG-\*4〗〖XCs.TIF;%80%80〗〖KG-\*9〗BROWSKI A,et al.Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma[J].Pol Przegl Chir,2012,84(7):341-347.
[33] GU Y,JIN S,WANG F,et al.Clinicopathological significance of PI3K,Akt and survivin expression in gastric cancer[J].Biomed Pharmacother,2014,68(4):471-475.
[34] MIYACHI K,FUJITA M,TANAKA N,et al.Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer[J].J Exp Clin Cancer Res,2002,21(2):269-275.
[35] TSUBURAYA A,NOGUCHI Y,YOSHIKAWA T,et al.An anti-apoptosis gene,survivin and telomerase expression in gastric cancer[J].Hepatogastroenterology,2002,49(46):1150-1152.
[36] HOU W,KONG L,HOU Z,et al.CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer[J].BMC Med Genomics,2022,15(1):225.
[37] XIE J W,CHEN P C,ZHENG C H,et al.Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer[J].J Cancer Res Clin Oncol,2015,141(10):1809-1817.
相似文献/References:
[1]陈赜,陈杰,严想元,等.腹腔镜辅助胃癌根治术治疗早期胃癌疗效观察[J].新乡医学院学报,,():000.
[2]于成功,萧树东,赵宪邨,等.胃癌胃良性病变患者血清和局部组织中IL—I水平及意义[J].新乡医学院学报,1996,13(03):220.
[3]王淑秀,赵卫星,和瑞芝,等.P~(53)和rasP~(21)在胃癌中表达的免疫组化研究[J].新乡医学院学报,1997,14(02):137.
[4]赵卫星,王淑秀,卢朝晖,等.幽门螺杆菌与胃癌基因抑癌基因突变的关系[J].新乡医学院学报,1997,14(03):203.
[5]王淑秀.抑癌基因和癌基因与胃癌[J].新乡医学院学报,1997,14(01):083.
[6]冯艳玲,乐晓萍,蔡新华.胃癌患者P16和P53蛋白的表达及其相互关系[J].新乡医学院学报,2000,17(06):403.
[7]周玲生.纤维胃镜粘膜活检1356 例病理分析[J].新乡医学院学报,2000,17(06):462.
[8]任金萍,王淑秀,付华民,等.青年与老年人胃癌中PCNA和AgNOR计数表达的对比研究[J].新乡医学院学报,2000,17(03):156.
[9]窦天伟,刘 炯,罗志勇,等.复发胃癌再次手术42例疗效和随访结果[J].新乡医学院学报,2003,20(05):337.
[10]张德志,王全志,张永辉.增殖细胞核抗原表达与胃癌演变及预后的关系[J].新乡医学院学报,2004,21(02):000.
[11]贾文英,张合喜,马彦民.幽门螺杆菌感染与胃癌关系的Meta 分析[J].新乡医学院学报,2000,17(05):328.
[12]李 婷.血清胃蛋白酶原和幽门螺杆菌抗体检测在胃癌早期筛查中的应用价值[J].新乡医学院学报,2016,33(10):913.[doi:10.7683/xxyxyxb.2016.10.021]
LI Ting.Value of serum pepsinogen and Helicobacter pylori antibody detection in screening early gastric carcinoma[J].Journal of Xinxiang Medical University,2016,33(8):913.[doi:10.7683/xxyxyxb.2016.10.021]